Related references
Note: Only part of the references are listed.NanoBRET-A Novel BRET Platform for the Analysis of Protein-Protein Interactions
Thomas Machleidt et al.
ACS CHEMICAL BIOLOGY (2015)
Deciphering the Cellular Targets of Bioactive Compounds Using a Chloroalkane Capture Tag
Rachel Friedman Ohana et al.
ACS CHEMICAL BIOLOGY (2015)
Application of BRET to monitor ligand binding to GPCRs
Leigh A. Stoddart et al.
NATURE METHODS (2015)
Cell-Based Protein Stabilization Assays for the Detection of Interactions between Small-Molecule Inhibitors and BRD4
Jessica Schulze et al.
JOURNAL OF BIOMOLECULAR SCREENING (2015)
Prodrug Applications for Targeted Cancer Therapy
Irene Giang et al.
AAPS JOURNAL (2014)
Chemoproteomics Reveals Time-Dependent Binding of Histone Deacetylase Inhibitors to Endogenous Repressor Complexes
Isabelle Becher et al.
ACS CHEMICAL BIOLOGY (2014)
Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring
Rudolf Griss et al.
NATURE CHEMICAL BIOLOGY (2014)
The cellular thermal shift assay for evaluating drug target interactions in cells
Rozbeh Jafari et al.
NATURE PROTOCOLS (2014)
Tracking cancer drugs in living cells by thermal profiling of the proteome
Mikhail M. Savitski et al.
SCIENCE (2014)
Histone Deacetylase Inhibitor Romidepsin Induces HIV Expression in CD4 T Cells from Patients on Suppressive Antiretroviral Therapy at Concentrations Achieved by Clinical Dosing
Datsen George Wei et al.
PLOS PATHOGENS (2014)
Structural basis for the design and synthesis of selective HDAC inhibitors
Simone Di Micco et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands
Georges Vauquelin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Chaperones as thermodynamic sensors of drug-target interactions reveal kinase inhibitor specificities in living cells
Mikko Taipale et al.
NATURE BIOTECHNOLOGY (2013)
Determining target engagement in living systems
Gabriel M. Simon et al.
NATURE CHEMICAL BIOLOGY (2013)
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Daniel Martinez Molina et al.
SCIENCE (2013)
Engineered Luciferase Reporter from a Deep Sea Shrimp Utilizing a Novel Imidazopyrazinone Substrate
Mary P. Hall et al.
ACS CHEMICAL BIOLOGY (2012)
Discovery and activity profiling of thailandepsins A through F, potent histone deacetylase inhibitors, from Burkholderia thailandensis E264
Cheng Wang et al.
MEDCHEMCOMM (2012)
Thailandepsins are new small molecule class I HDAC inhibitors with potent cytotoxic activity in ovarian cancer cells: a preclinical study of epigenetic ovarian cancer therapy
Andrew J. Wilson et al.
JOURNAL OF OVARIAN RESEARCH (2012)
Setting Up a Bioluminescence Resonance Energy Transfer High throughput Screening Assay to Search for Protein/Protein Interaction Inhibitors in Mammalian Cells
Cyril Couturier et al.
Frontiers in Endocrinology (2012)
Detection of Allosteric Kinase Inhibitors by Displacement of Active Site Probes
Connie S. Lebakken et al.
JOURNAL OF BIOMOLECULAR SCREENING (2012)
Real-Time Imaging of Histone H4K12-Specific Acetylation Determines the Modes of Action of Histone Deacetylase and Bromodomain Inhibitors
Tamaki Ito et al.
CHEMISTRY & BIOLOGY (2011)
Thailandepsins: Bacterial Products with Potent Histone Deacetylase Inhibitory Activities and Broad-Spectrum Antiproliferative Activities
Cheng Wang et al.
JOURNAL OF NATURAL PRODUCTS (2011)
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
Marcus Bantscheff et al.
NATURE BIOTECHNOLOGY (2011)
Comprehensive analysis of kinase inhibitor selectivity
Mindy I. Davis et al.
NATURE BIOTECHNOLOGY (2011)
HaloTag-based purification of functional human kinases from mammalian cells
Rachel Friedman Ohana et al.
PROTEIN EXPRESSION AND PURIFICATION (2011)
A Bioluminogenic HDAC Activity Assay: Validation and Screening
Francoise Halley et al.
JOURNAL OF BIOMOLECULAR SCREENING (2011)
Drug-target residence time: critical information for lead optimization
Hao Lu et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis
Roel H. Wilting et al.
EMBO JOURNAL (2010)
Rebinding: or why drugs may act longer in vivo than expected from their in vitro target residence time
Georges Vauquelin
EXPERT OPINION ON DRUG DISCOVERY (2010)
Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression
Teppei Yamaguchi et al.
GENES & DEVELOPMENT (2010)
Quantitative determination of protein stability and ligand binding using a green fluorescent protein reporter system
Morgane J. J. Moreau et al.
MOLECULAR BIOSYSTEMS (2010)
Chemical phylogenetics of histone deacetylases
James E. Bradner et al.
NATURE CHEMICAL BIOLOGY (2010)
Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining
Kyle M. Miller et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
A Fluorescent Ligand-Binding Alternative Using Tag-lite (R) Technology
Jurriaan M. Zwier et al.
JOURNAL OF BIOMOLECULAR SCREENING (2010)
Direct comparison of bioluminescence-based resonance energy transfer methods for monitoring of proteolytic cleavage
Helen Dacres et al.
ANALYTICAL BIOCHEMISTRY (2009)
Direct comparison of fluorescence- and bioluminescence-based resonance energy transfer methods for real-time monitoring of thrombin-catalysed proteolytic cleavage
H. Dacres et al.
BIOSENSORS & BIOELECTRONICS (2009)
HDAC family: What are the cancer relevant targets?
Olaf Witt et al.
CANCER LETTERS (2009)
Development and Applications of a Broad-Coverage, TR-FRET-Based Kinase Binding Assay Platform
Connie S. Lebakken et al.
JOURNAL OF BIOMOLECULAR SCREENING (2009)
Characterisation of the in vitro activity of the depsipeptide histone deacetylase inhibitor spiruchostatin A
Simon J. Crabb et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Residence time of receptor-ligand complexes and its effect on biological function
Peter J. Tummino et al.
BIOCHEMISTRY (2008)
Evaluation of the pharmacodynamic effects of MGCD0103 from preclinical models to human using a novel HDAC enzyme assay
Claire Bonfils et al.
CLINICAL CANCER RESEARCH (2008)
MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo
Marielle Fournel et al.
MOLECULAR CANCER THERAPEUTICS (2008)
A quantitative analysis of kinase inhibitor selectivity
Mazen W. Karaman et al.
NATURE BIOTECHNOLOGY (2008)
Opinion - Drug-target residence time and its implications for lead optimization
Robert A. Copeland et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Characterization of the two catalytic domains in histone deacetylase 6
H Zou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Illuminating insights into protein-protein interactions using bioluminescence resonance energy transfer (BRET)
KDG Pfleger et al.
NATURE METHODS (2006)
Two catalytic domains are required for protein deacetylation
Y Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Bioluminescence resonance energy transfer (BRET) for the real-time detection of protein-protein interactions
Kevin D. G. Pfleger et al.
NATURE PROTOCOLS (2006)
Toward selective histone deacetylase inhibitor design: Homology modeling, docking studies, and molecular dynamics simulations of human class I histone deacetylases
DF Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3
MG Guenther et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Share Paper
